Emergent BioSolutions Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Emergent BioSolutions Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Emergent BioSolutions Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $77.9M.
  • Emergent BioSolutions Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$26.8M, a 13300% decline year-over-year.
  • Emergent BioSolutions Inc. annual Nonoperating Income (Expense) for 2023 was -$4.8M, a 90.2% increase from 2022.
  • Emergent BioSolutions Inc. annual Nonoperating Income (Expense) for 2022 was -$49M, a 28.3% decline from 2021.
  • Emergent BioSolutions Inc. annual Nonoperating Income (Expense) for 2021 was -$38.2M, a 43.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$26.8M $77.9M +$102M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$129M -$66.3M -$109M -255% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$19.5M -$27.7M -$14.7M -113% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$4.8M -$10.7M -$4.6M -75.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$200K -$23.8M -$1.9M -8.68% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $1.7M $42.7M +$53.5M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$51.8M -$13M -$2.8M -27.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$49M -$6.1M +$3.8M +38.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$52.8M -$21.9M -$11.1M -103% Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
Q2 2022 -$41.7M -$10.8M -$3.5M -47.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$38.2M -$10.2M $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$38.2M -$9.9M -$4.6M -86.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-08
Q3 2021 -$33.6M -$10.8M -$4.5M -71.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$29.1M -$7.3M -$2M -37.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$27.1M -$10.2M -$500K -5.16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 -$26.6M -$5.3M +$900K +14.5% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-12-11
Q3 2020 -$27.5M -$6.3M +$5.5M +46.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$33M -$5.3M +$2.8M +34.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$35.8M -$9.7M +$900K +8.49% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$36.7M -$6.2M +$1.4M +18.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$38.1M -$11.8M -$12M -6000% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$26.1M -$8.1M -$7.1M -710% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$19M -$10.6M -$10.7M -10700% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$8.3M -$7.6M -$6.43M -548% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 -$1.87M $200K +$1.66M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$3.53M -$1M +$808K +44.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 -$4.34M $100K +$1.37M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$5.7M -$1.17M +$633K +35.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$6.33M -$1.46M +$470K +24.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 -$6.8M -$1.81M -$541K -42.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$6.26M -$1.27M +$38K +2.92% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$6.3M -$1.81M -$350K -24.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 -$5.95M -$1.93M -$913K -90.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$5.04M -$1.27M +$585K +31.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$5.62M -$1.3M +$176K +11.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 -$5.8M -$1.46M -$1.14M -366% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-23
Q3 2015 -$4.66M -$1.01M +$319K +24% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$4.97M -$1.85M -$1.48M -403% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$3.49M -$1.48M +$1.5M +50.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$4.99M -$312K -$677K -185% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 -$4.32M -$1.33M -$1.48M -1012% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$2.84M -$368K -$393K -1572% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$2.45M -$2.98M -$3.01M -10386% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $565K $365K +$118K +47.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $447K $146K +$107K +274% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $340K $25K -$911K -97.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $1.25M $29K -$847K -96.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $2.1M $247K +$475K Oct 1, 2012 Dec 31, 2012 10-K/A 2015-03-09
Q3 2012 $1.62M $39K -$20K -33.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $1.64M $936K +$957K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $686K $876K +$842K +2476% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 -$156K -$228K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-10
Q3 2011 $59K +$1.02M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 -$21K -$401K -106% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 $34K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 -$965K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $380K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.